Please select the option that best describes you:
How would you treat a potentially resectable stage III lung adenocarcinoma with an EGFR mutation?
Do you consider any neoadjuvant therapy or proceed to surgery followed by adjuvant chemotherapy and osimertinib? Does the type of mutation (ex a rare exon 19 mutation) change affect your decision?
Answer from: Medical Oncologist at Academic Institution
How would you treat a potentially resectable stage III adenocarcinoma with an EGFR mutation? Do you consider any neoadjuvant therapy or proceed to surgery followed by adjuvant chemotherapy and osimertinib? This is a very challenging patient scenario that we face with some frequency and it truly...
Sign in or Register to read more